Substance use at admission to an acute psychiatric department

Nordic Journal of Psychiatry

Volumn 63, Issue 2, 2009, Pages 113-119

  Fløvig, John Christian ^a,b   Vaaler, Arne Einar ^a,b   Morken, Gunnar ^a,b  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Acute psychiatry; Alcohol; Drug; Medication; Substance

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; ALPRAZOLAM; AMOBARBITAL; AMPHETAMINE; BENZODIAZEPINE; BUPRENORPHINE; BUTALBITAL; CANNABIS; CLONAZEPAM; COCAINE; CODEINE; DIAZEPAM; EPHEDRINE; FLUNITRAZEPAM; HEXOBARBITAL; LYSERGIDE; MORPHINE; NITRAZEPAM; OPIATE; OXAZEPAM; PARACETAMOL; PHENCYCLIDINE; PHENOBARBITAL; PSILOCYBINE; SECOBARBITAL; THIOPENTAL; UNINDEXED DRUG; ZOLPIDEM; ZOPICLONE;

ADULT; ARTICLE; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MENTAL DISEASE; PREVALENCE; PSYCHIATRIC DEPARTMENT; PSYCHIATRIC DIAGNOSIS; SUBSTANCE ABUSE; URINALYSIS; ACUTE DISEASE; ADDICTION; COMORBIDITY; NORWAY; PSYCHOLOGIC TEST; SEX RATIO; STATISTICS; URINE;

ACUTE DISEASE; ADULT; CHROMATOGRAPHY, LIQUID; COMORBIDITY; FEMALE; HOSPITALIZATION; HUMANS; INTERVIEW, PSYCHOLOGICAL; LENGTH OF STAY; MALE; MASS SPECTROMETRY; MENTAL DISORDERS; NORWAY; PREVALENCE; PSYCHIATRIC DEPARTMENT, HOSPITAL; SEX DISTRIBUTION; SUBSTANCE-RELATED DISORDERS;

EID: 66149103664     PISSN: 08039488     EISSN: 15024725     Source Type: Journal    
DOI: 10.1080/08039480802294787     Document Type: Article

References (40)

1. Schiller, MJ, Shumway, M. and Batki, SL. (2000) Patterns of substance use among patients in an urban psychiatric emergency service. Psychiatr Serv, 51, pp. 113-115.
2. Lejoyeux, M., Boulenguiez, S., Fichelle, A., McLoughlin, M., Claudon, M. and Ades, J. (2000) Alcohol dependence among patients admitted to psychiatric emergency services. Gen Hosp Psychiatry, 22, pp. 206-212.
3. Bonsack, C., Camus, D., Kaufmann, N., Aubert, AC, Besson, J. Baumann, P. et al. (2006) Prevalence of substance use in a Swiss psychiatric hospital: Interview reports and urine screening. Addict Behav, 31, pp. 1252-1258.
4. Hansen, SS, Munk-Jorgensen, P., Guldbaek, B., Solgard, T., Lauszus, KS Albrechtsen, N. et al. (2000) Psychoactive substance use diagnoses among psychiatric in-patients. Acta Psychiatr Scand, 102, pp. 432-438.
5. Vaaler, AE, Morken, G., Flovig, JC, Iversen, VC and Linaker, AM. (2006) Substance abuse and recovery in a psychiatric intensive care unit. General Hospital Psychiatry, 28, pp. 65-70.
6. Ries, RK, Russo, J., Wingerson, D., Snowden, M., Comtois, KA Srebnik, D. et al. (2000) Shorter hospital stays and more rapid improvement among patients with schizophrenia and substance disorders. Psychiatr Serv, 51, pp. 210-215.
7. Szuster, RR, Schanbacher, BL, McCann, SC and McConnell, A. (1990) Underdiagnosis of psychoactive-substance-induced organic mental disorders in emergency psychiatry. Am J Drug Alcohol Abuse, 16, pp. 319-327.
8. Kessler, RC, McGonagle, KA, Zhao, S., Nelson, CB, Hughes, M. Eshleman, S. et al. (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry, 51, pp. 8-19.
9. Wittchen, HU and Jacobi, F. (2005) Size and burden of mental disorders in Europe-A critical review and appraisal of 27 studies. Eur Neuropsychopharmacol, 15, pp. 357-376.
10. Regier, DA, Farmer, ME, Rae, DS, Locke, BZ, Keith, SJ Judd, LL et al. (1990) Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA, 264, pp. 2511-2518.
11. Compton, WM, Thomas, YF, Stinson, FS and Grant, BF. (2007) Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry, 64, pp. 566-576.
12. Lambert, MT, Griffith, JM and Hendrickse, W. (1996) Characteristics of patients with substance abuse diagnoses on a general psychiatry unit in a VA Medical Center. Psychiatr Serv, 47, pp. 1104-1107.
13. Mueser, KT, Yarnold, PR, Rosenberg, SD, Swett, C., Miles, KM and Hill, D. (2000) Substance use disorder in hospitalized severely mentally ill psychiatric patients: Prevalence, correlates, and subgroups. Schizophr Bull, 26, pp. 179-192.
14. Ananth, J., Vandewater, S., Kamal, M., Brodsky, A., Gamal, R. and Miller, M. (1989) Missed diagnosis of substance abuse in psychiatric patients. Hosp Community Psychiatry, 40, pp. 297-299.
15. Ries, RK, Demirsoy, A., Russo, JE, Barrett, J. and Roy-Byrne, PP. (2001) Reliability and clinical utility of DSM-IV substance-induced psychiatric disorders in acute psychiatric inpatients. Am J Addict, 10, p. 4.
16. Way, BB, Allen, MH, Mumpower, JL, Stewart, TR and Banks, SM. (1998) Interrater agreement among psychiatrist in psychiatric emergency assessments. Am J Psychiatry, 155, pp. 1423-1428.
17. EMCDDA (2006)European Monitoring Centre for Drugs and Drug Addiction, Lisbon
18. McLellan, AT, Luborsky, L., Woody, GE and O'Brien, CP. (1980) An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis, 168, pp. 26-33.
19. Saunders, JB, Aasland, OG, Babor, TF, de Jr., lF and Grant, M. (1993) Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption-II. Addiction, pp. 791-804.
20. Berman, AH, Bergman, H., Palmstierna, T. and Schlyter, F. (2005) Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. Eur Addict Res, 11, pp. 22-31.
21. Rehm, J., Room, R., van den Brink, W and Kraus, L. (2005) Problematic drug use and drug use disorders in EU countries and Norway: An overview of the epidemiology. Eur Neuropsychopharmacol, 15, pp. 389-397.
22. Frischer, M., Hickman, M., Kraus, L., Mariani, F. and Wiessing, L. (2001) A comparison of different methods for estimating the prevalence of problematic drug misuse in Great Britain. Addiction, 96, pp. 1465-1476.
23. Hammett-Stabler, CA, Pesce, AJ and Cannon, DJ. (2002) Urine drug screening in the medical setting. Clinica Chimica Acta, 315, pp. 125-135.
24. Ley, A., Jeffery, D., Ruiz, J., McLaren, S. and Gillespie, C. (2002) Underdetection of comorbid drug use at acute psychiatric admission. Psychiatr Bull R Coll Psychiatr, 26, pp. 248-251.
25. Perrone, J., De Roos, F., Jayaraman, S. and Hollander, JE. (2001) Drug screening versus history in detection of substance use in ED psychiatric patients. Am J Emerg Med, 19, pp. 49-51.
26. Schiller, MJ, Shumway, M. and Batki, SL. (2000) Utility of routine drug screening in a psychiatric emergency setting. Psychiatr Serv, 51, pp. 474-478.
27. Claassen, CA, Gilfillan, S., Orsulak, P., Carmody, TJ, Battaglia, J. and Rush, AJ. (1997) Substance use among patients with a psychotic disorder in a psychiatric emergency room. Psychiatr Serv, 48, pp. 353-358.
28. Elangovan, N., Berman, S., Meinzer, A., Gianelli, P., Miller, H. and Longmore, W. (1993) Substance abuse among patients presenting at an inner-city psychiatric emergency room. Hosp Community Psychiatry, 44, pp. 782-784.
29. Clayton, RR, Voss, HL, Robbins, C. and Skinner, WF (1986) National Institute on Drug Abuse, pp. 81-99.
30. Magrini, N., Vaccheri, A., Parma, E., D'Alessandro, R., Bottoni, A. Occhionero, M. et al. (1996) Use of benzodiazepines in the Italian general population: Prevalence, pattern of use and risk factors for use. Eur J Clin Pharmacol, 50, pp. 19-25.
31. van Hulten, R., Leufkens, HG and Bakker, A. (1998) Usage patterns of benzodiazepines in a Dutch community: A 10-year follow-up. Pharm World Sci, 20, pp. 78-82.
32. Zandstra, SM, Furer, JW, van de Lisdonk, EH, van't Hof, M, Bor, JH van Weel, C. et al. (2002) Different study criteria affect the prevalence of benzodiazepine use. Soc Psychiatry Psychiatr Epidemiol, 37, pp. 139-144.
33. World Health Organization (1993) The ICD-10 classification of mental and behavioural disorders: Diagnostic criteria for research, World Health Organization, Geneva, Switzerland
34. Tsuno, N., Besset, A. and Ritchie, K. (2005) Sleep and depression. J Clin Psychiatry, 66, pp. 1254-1269.
35. Miele, GM, Carpenter, KM, Cockerham, MS, Trautman, KD, Blaine, J. and Hasin, DS. (2001) Substance Dependence Severity Scale-Reliability and validity for ICD-10 substance use disorders. Addictive Behaviors, 26, pp. 603-612.
36. Szuster, RR, Schanbacher, BL and McCann, SC. (1990) Characteristics of psychiatric emergency room patients with alcohol- or drug-induced disorders. Hosp Community Psychiatry, 41, pp. 1342-1345.
37. Kringlen, E., Torgersen, S. and Cramer, V. (2001) A Norwegian psychiatric epidemiological study. Am J Psychiatry, 158, pp. 1091-1098.
38. Rehm, J., Room, R., van den Brink, W and Jacobi, F. (2005) Alcohol use disorders in EU countries and Norway: An overview of the epidemiology. Eur Neuropsychopharmacol, 15, pp. 377-388.
39. Kraus, L., Augustin, R., Frischer, M., Kummler, P., Uhl, A. and Wiessing, L. (2003) Estimating prevalence of problem drug use at national level in countries of the European Union and Norway. Addiction, 98, pp. 471-485.
40. Modestin, J., Nussbaumer, C., Angst, K., Scheidegger, P. and Hell, D. (1997) Use of potentially abusive psychotropic substances in psychiatric inpatients. Eur Arch Psychiatry Clin Neurosci, 247, pp. 146-153.